Jennifer Malinowski

Should NIH fund universal DNA analysis in babies? Ask @NICHD_NIH director @DianaBianchiMD and @genomedotgov GenomicMed director @manoliote at world's first scientific conf on #newbornsequencing October 5-6 in Boston. Details/registration: @ICoNSeqInt Retweeted by Jennifer Malinowski, PhD

The Department of Human Genetics has two open faculty searches this year! 1) Computational Genomics (deadline Nov 11): 2) Evolutionary, functional, and human/medical genetics (deadline (Nov 1): Please apply and spread the word. Retweeted by Jennifer Malinowski, PhD

What are people saying about #PBMs? Senior Counsel Health Policy at the American Benefits Council, Katy Johnson, explains that “employers are deeply concerned about the absence of appropriate price and cost transparency.” Read More:… Retweeted by Jennifer Malinowski, PhD

@carrieprice78 As a reviewer I always note when the authors say this. Drives me nuts!

I think this is a great read for anyone in epidemiology. The nature of the (drug) exposures in #rxepi make it easy to illustrate some of the important challenges that affect all of Epi.… Retweeted by Jennifer Malinowski, PhD

🤓 Systematic Reviews can bringing attention to fake studies, writes @cochranecollab Senior Research Integrity Editor, Lisa Bero in @ConversationUS ➡️ 💜 Learn about what Cochrane is doing about this issue ➡️ Retweeted by Jennifer Malinowski, PhD

Join the lab! We're hiring two postdocs, on genomics of 1.) malaria and 2.) mosquitoes. There's flexibility in focus since we're starting up work in Madagascar/Uganda. If you can deal with big DNA/RNA datasets (no matter the species), give me a holler. Retweeted by Jennifer Malinowski, PhD

@sbarolo @thestorygraph Thanks for sharing this! I wasn’t aware of @thestorygraph and will happily move from goodreads!

This is so real - until we figure this part out, I'm not sure actionable results are really all that actionable. #GeneChat… Retweeted by Jennifer Malinowski, PhD

The realization I totally missed #hcldr chat tonight 🤦‍♀️ setting a reminder for next week!

In a country as wealthy as the United States, it is unconscionable that a person’s access to #healthcare often comes down to skin color, gender, income, geography, disability, and employment or immigration status. Retweeted by Jennifer Malinowski, PhD

In the latest Marketplace Pulse from @RWJF, @khemp64 writes about the threats to coverage and reproductive freedom will deepen the inequities inherent in the post-Dobbs world — and why Congress must take action now. Retweeted by Jennifer Malinowski, PhD

Thanks for the warm welcome and great discussion! #hcldr

@abnermason I'll add an effective way to catalyze change/innovation, is to couch it in terms that resonate w/ the individual who the change will affect. "This will help us be more effective." "This will make us profitable." "This will allow for cross-training." Find the motivator! #hcldr T4 Retweeted by Jennifer Malinowski, PhD

@KarenATXMH This is so important! I love being able to include patients/advocates in guideline dev because their experience is so valuable. Goes back to being comfortable w/uncomfortable situations.

Q4 Echo chambers happen when no one in the room leaves the room and just keeps talking. Action is the best prevention of an echo chamber. Take a step, then another, and soon you'll be on a journey. Respect those who say no by gently encouraging them to get on the bus #hcldr Retweeted by Jennifer Malinowski, PhD

T4: The most effective way to convince healthcare to take risk: 1. Show how innovation can advance an organization's goals 2. Show examples of similar successes 3. Measure progress and adapt accordingly Good ideas don't always change healthcare, but good plans can. #hcldr Retweeted by Jennifer Malinowski, PhD

T4: tough question! I’m forever the kid who asks Why when I’m told no, but I hope I’ve matured enough to understand that the bigger picture looks different to others. It takes leadership to facilitate a good balance of yes/no, risk/reward #hcldr

Posted in .

Dana Crawford

Professor of Population and Quantitative Health Sciences and Associate Director of the Cleveland Institute for Computational Biology, with interest in pharmacogenomics, electronic health records, and diverse populations. Also, an avid foodie!